Turning Point Therapeutics Inc
TPTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$85.97
13.9% upside
Current Fair Value
13.9% upsideUndervalued by 13.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-285,210,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.79 |
| Beta | -0.19 |
| Outstanding Shares | 49,702,860 |
Return
| Return on Equity | -43.16% |
|---|---|
| Return on Assets | -40.59% |
| Return on Invested Capital | -43.12% |
Valuation & Multiples
| P/E Ratio | -13.03 |
|---|---|
| PEG | -10.98 |
| Price to Sales | - |
| Price to Book Ratio | 5.03 |
| Enterprise Value to Revenue | -276.04 |
| Enterprise Value to EBIT | 0.83 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data